MoneyWorks4Me

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, DIL has informed that the officials of the company will be interacting with investors on 4th December 2018. This is to further inform that the Investor Presentation ‘November 2018’ to be discussed with Investors in the above interaction, which has already been uploaded on the website of the company www.dil.net and is also available on BSE website, www.bseindia.com. This information is submitted pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. It is also informed that changes may happen due to exigencies on the part of Host / Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..